Introduction
The p21 CIP1/WAF1 (CAP20/mda6/sdi1) gene product functions as an inhibitor of multiple cyclin-dependent kinases (Xiong et al., 1993; Harper et al., 1995; Gu et al., 1993) . A role for this protein in the growth arrest associated with naturally-occurring biological processes was initially suggested by the isolation of the gene from both dierentiating melanocytes (Jiang et al., 1996) and senescing ®broblasts (Noda et al., 1994) . p21 CIP1/WAF1 mediated blocking of cell cycle progression was linked with the tumor suppressor pathway of p53 when p21 CIP1/WAF1 was independently isolated followed subtractive hybridization of cDNA from glioblastoma multiforme cells overexpressing exogenous wildtype p53 (El-Deiry et al., 1993) . p21 CIP1/WAF1 expression following DNA damage by radiation or chemotherapeutic agents appears to be mediated by p53 since expression is induced in cells exhibiting functional p53, but not in cells bearing mutations or deletions in the p53 gene (Bae et al., 1995; El-Deiry et al., 1994; Liu and Pelling, 1996) . However, p53-independent regulation of p21 CIP1/WAF1 has been described also (Parker et al., 1995; Zeng and El-Deiry 1996; Michieli et al., 1994; Russo et al., 1995) . Nevertheless, overexpression of p21 CIP1/WAF1 in tumor cells with p53 mutations overcomes the loss of growth control and causes growth inhibition, suggesting p21 CIP1/WAF1 functions as a downstream eector of tumor growth suppression by p53 (El-Deiry et al., 1993) . Fibroblasts from genetically engineered mice harboring a mutation in the p21 CIP1/WAF1 gene share a defect in G1 checkpoint control and increased saturation density with p53-null ®broblasts (Brugarolas et al., 1995; Deng et al., 1995) . In contrast, p21 CIP1/WAF1 -null mice do not exhibit the decrease in thymocyte apoptosis, mitotic spindle checkpoint or frequency of spontaneous tumors associated with loss of p53 function, suggesting p53 provides functions in addition to transcriptional regulation of the p21 CIP1/WAF1 gene (Deng et al., 1995) . We have previously shown that cultured keratinocytes from p53-null mice initiated by introduction of the v-ras Ha oncogene in vitro and grafted to a skin site in vivo form rapidly growing tumors that progress to poorly dierentiated carcinomas within several weeks (Weinberg et al., 1994) . This correlated with decreased basal levels of p21 CIP1/WAF1 mRNA in cultured keratinocytes from these mice and a reduced response to negative growth regulators such as Ca 2+ and TGF-b (Weinberg et al., 1994) . Similarly, p53-null mouse skin, initiated with topical carcinogen treatment in vivo, had a much increased rate of conversion from skin papillomas to poorly dierentiated carcinomas (Kemp et al., 1993) . In this study we have utilized keratinocytes from mice expressing a null mutation in the p21 CIP1/WAF1 gene to examine whether a reduction in p21 CIP1/WAF1 determines the acceleration of malignant conversion and loss of dierentiated phenotype detected in tumors from the p53-de®cient initiated keratinocytes.
Results

Skin tumors from p21
CIP1/WAF1 -null keratinocytes are primarily papillomas with focal dysplasia or carcinoma To test whether the decreased levels of p21 CIP1/WAF1 contribute to altered tumor growth, keratinocytes were isolated from mice diering in p21 CIP1/WAF1 gene status, initiated by introduction of the v-ras Ha oncogene, and grafted to nude mouse hosts to follow phenotype. As shown in Figure 1a (top panel), the tumors derived from all genotypes were predominantly well-differentiated papillomas. Many of these contained small foci of dysplastic papilloma or well-dierentiated carcinoma ( Figure 1a , bottom panel), however the conversion frequency of the papillomas was equally distributed among the genotypes, ranging from 30 ± 44% (Table 1) . In addition to the major papilloma component, some tumors contained subcutaneous nodules of converted carcinoma foci, but these were distributed across the genotypes, and there was no dierence in size of these nodules depending on the genotype (not shown).
To detect subtle dierences in tumor progression between the genotypes, tumor sections were stained for keratins that are associated with speci®c stages of tumor progression (Tennenbaum et al., 1993) . Loss of the dierentiation-speci®c K1 and induction of K13 is associated with premalignant progression, while K8 expression correlates with malignant conversion. All of these markers were present in each of the tumors examined, and the pattern of expression of these markers was independent of genotype (data not -null cells which might in¯uence the tumor phenotype, tumor lysates were analysed by Western blot for the expression of the v-ras Ha oncogene product ( Figure 1b) . Ras expression levels varied between tumors. To compare relative epithelial cell content in the tumors, blots were also reacted with antibody to epithelial speci®c K14. V-ras protein is seen as a doublet diering in phosphorylation status (Brown et al., 1986) and was expressed in tumors of all genotypes. Expression levels between the tumors were somewhat variable but unrelated to the dierences in genotype.
p21
CIP1/WAF1 gene dose marginally eects growth of tumors and keratinocytes in the presence of v-ras
Ha
We have previously demonstrated that de®ciency of p53 in v-ras Ha keratinocyte tumors enhances the rate of tumor growth (Weinberg et al., 1994) . To determine whether this is mediated through the p21
pathway, tumor volume was determined and compared between the genotypes. Fifteen days after grafting, tumor sizes were similar among the three genotypes. At 21 days following grafting, there was greater variation in tumor volume within each group; however neither the tumors derived from p21 CIP1/WAF1 +/7 nor tumors from 7/7 keratinocytes were signi®cantly dierent in volume from +/+ controls (Figure 2a ) (P=0.51 and P=0.40 respectively by Wilcoxon rank sum test). Keratinocytes expressing vras Ha were also assayed in vitro for dierences in responsiveness to negative growth regulation, since keratinocytes de®cient in p53 and expressing v-ras Ha were previously shown to be relatively resistant to TGF-b and Ca 2+ -induced growth inhibition (Weinberg et al., 1994) . There was no dierence in growth suppression of keratinocytes expressing v-ras +/+ and 7/7 genotypes were at borderline statistical signi®cance at 0.2 ng/ml TGF-b (P=0.05), but not at the higher doses of 1.0 and 2.0 ng/ml (P=0.1 for each).
Papillomas were evaluated for the percent of nuclei undergoing DNA synthesis by counting BrdU labeled cells in tumor sections. The % labeled nuclei in tumors 3 weeks following grafting was 54.2, 30.5 and 36.6 in p21 CIP1/WAF1 +/+, +/7 and 7/7 tumors, respectively, suggesting again that loss of p21 CIP1/WAF1 does not increase the proliferating compartment of epidermal tumors.
Discussion
In this study we have explored the contribution of the p21 -induced terminal dierentiation of cultured keratinocytes (Weinberg et al., 1995; Missero et al., 1995) ; p21 CIP1/WAF1 levels are also upregulated following exposure of keratinocytes to u.v. radiation (El-Deiry et al., 1995; Liu and Pelling, 1996) . In many cell types, loss of p21 CIP1/WAF1 abrogates the p53-mediated G1 arrest normally induced by DNA damage (Deng et al., 1995; Brugarolas et al., 1995; Waldman et al., 1995) . In addition, it has been proposed that negative growth regulation by TGF-b, a major regulator of epidermal cell proliferation, is mediated through the p21 CIP1/WAF1 pathway Datto et al., 1995) . We demonstrate in this study that while p21
-de®cient keratinocytes expressing v-ras Ha display decreased responsiveness to TGF-b in vitro, they do not display the decreased responsiveness to negative growth regulation by Ca 2+ or the increased growth observed in p53-de®cient tumors in vivo (Weinberg et al., 1994) .
The regressing nature of benign tumors may be explained by self-limiting growth due to apoptosis or dierentiation. In situ hybridization analyses of multiple organs revealed that p21 CIP1/WAF1 expression correlates with terminal dierentiation independent of functional p53 (Parker et al., 1995) . Recent studies exploring the relationship between p21 CIP1/WAF1 and p53 expression levels in human colon tumors have demonstrated that lower disease stage correlates with higher p21 CIP1/WAF1 expression, not necessarily dependent on p53 status (Matsushita et al., 1996; Doglioni et al., 1996) . In our study the loss of p21 CIP1/WAF1 expression does not cause loss of the benign phenotype, as evidenced by the well dierentiated papilloma component comprising the bulk of each tumor. Likewise, the ability of keratinocytes to express keratin 1, a marker of suprabasal dierentiation, in vivo is unaltered by p21 CIP1/WAF1 gene status, even in the presence of v-ras Ha oncogene. The results presented here are in contrast to ®ndings recently reported by Missero et al. suggesting that p21 CIP1/WAF1 loss alters the dierentiation program of keratinocytes and yields an aggressive tumorigenic phenotype in the presence of the v-ras Ha oncogene (Missero et al., 1996) . While the background strain of the mice in this study is 129SVEV, the mice in the Missero study had been crossed with Black Swiss mice.
It is unclear what, if any, the contribution of this genetic dierence might be to tumor potential. However, 129SVEV mice have recently been shown to be very sensitive to chemical induction of skin tumors (Reiners and Kameshwar, 1997) . In addition, several dierences in technical approach could contribute to the observed dierences in tumor phenotype between these two studies. For example, it has been p21 CIP1/WAF1 gene loss and mouse skin carcinogenesis WC Weinberg et al previously demonstrated that elevated Ras levels correlate with increased malignancy in the mouse keratinocyte graft model (Brissette et al., 1993) and the viral construct used in the Missero study is designed for high expression (Missero et al., 1996) . Missero et al. also used EGF in the culture medium and this may select for dierent target cell populations with varying transformation potential, possibly related to p21 CIP1/WAF1 status, that were then pooled for tumor testing. In the study by Missero et al., tumors were evaluated following subcutaneous injection of isolated keratinocytes, whereas in the present study the transduced keratinocyte preparations were combined with dermal ®broblasts in a skin graft site to form a skin equivalent in vivo. The grafting model provides the epidermal-dermal interactions that modify tumor formation. The addition of normal dermal ®broblasts has previously been shown to suppress the aggressive nature of carcinomas arising in graft sites derived from elevated Ras levels (Dotto et al., 1988) , and previous studies of microcell hybrids have demonstrated that cells displaying a malignant phenotype following subcutaneous injection can be suppressed in the graft site (Conway et al., 1992) . Thus, the constraints of a subcutaneous environment on keratinocyte growth may allow expression of dierences in phenotype which are not observed under the more physiologic conditions present in a skin graft model. Together, the results of the two studies suggest that p21 CIP1/WAF1 gene dose alone may not account for increased malignant potential of CIP1/WAF1 gene loss and mouse skin carcinogenesis WC Weinberg et al squamous tumors but that decreased levels may provide a survival and growth advantage once outside their normal cellular context. Previously, p53-null mice were shown to form spontaneous tumors of numerous organ systems, and while there was no increase in papilloma formation following chemical-induction of skin tumors in these mice, those that arose were at high risk for malignant conversion (Kemp et al., 1993) . The p21 CIP1/WAF1 null mice do not share the incidence of spontaneous tumor formation, and we demonstrate here using a grafting model of v-ras Ha transduced keratinocytes that malignant conversion of epidermal papillomas in vivo is not enhanced by p21 CIP1/WAF1 de®ciency. Chemical carcinogenesis studies of these mice to access the contribution of p21 CIP1/WAF1 genotype and endogenous ras activation on papilloma formation and conversion frequency have not yet been reported and are currently underway in our laboratory.
The results presented here do not preclude the possibility that p21 CIP1/WAF1 induction mediated by p53 is a critical element in growth regulation of keratinocytes under conditions such as u.v. exposure, the most common environmental epidermal carcinogen of humans. However, the discordance between the tumor phenotype of p21 CIP1/WAF1 null keratinocytes shown here and p53 null keratinocytes (Weinberg et al., 1994) suggests that p53 must serve functions in addition to transcriptional regulation of the p21 CIP1/WAF1 gene product to suppress the malignant phenotype of vras-induced tumors. Likewise, p53-mediated transcription of genes other than p21
CIP1/WAF1 appears to be required for oncogene-mediated apoptosis (Attardi et al., 1996) . We have previously demonstrated that p53-mediated transcriptional activity increases following induction of terminal dierentiation of keratinocytes in vitro (Weinberg et al., 1995) . p21 CIP1/WAF1 mRNA increases under these conditions but independent of p53 (Weinberg et al., 1995; Missero et al., 1995) , suggesting the induction of additional gene products by p53 contributing to processes associated with keratinocyte dierentiation. We are current characterizing novel genes mediated by p53 in dierentiating keratinocytes which we have identi®ed using differential display. This approach may yield additional features of the p53 protein which may explain the decrease in terminal dierentiation associated with p53-null tumors.
Materials and methods
Keratinocyte preparation and genotyping
Mice expressing a null mutation in the p21 CIP1/WAF1 gene have been previously described (Deng et al., 1995) . Individual keratinocyte preparations were isolated from each of 22 newborn (1 ± 4 day old) ospring of heterozygous crosses (129SVEV background strain) and cultured in Eagle's Minimal Essential Medium containing 8% fetal calf serum and 0.05 mM Ca 2+ as previously described (Weinberg 1995) . Tail DNA of these mice was genotyped by polymerase chain reaction. A 430 bp fragment of the wildtype gene was ampli®ed using primer sequences 5'-TC-TTGTGTTTCAGCCACAGGC-3' and 5'-TGTCAGGCT-GGTCTGCCTCC-3'. The interrupted allele was identi®ed by ampli®cation of a 150 bp product with primers p21-5: 5'-ATTTTCCAGGGATCTGACTC-3' and R1N-1A: 5'-CCAGACTGCCTTGGGAAAAGC-3'. Genotypes were con®rmed on keratinocyte cell lines derived from each individual preparation.
Tumor production and analyses
Two days after plating, the cultures were incubated with 1610 6 virus particles/ml of replication-defective retrovirus encoding the v-ras Ha oncogene in the presence of polybrene (4 mg/ml) as previously described (Weinberg et al., 1994) . After 6 days in vitro, keratinocytes from each genotype, p21 CIP1/WAF1 +/+, +/7 and 7/7, were harvested by trypsinization and 5.0610 6 epithelial cells were combined with 6.0610 6 p21 CIP1/WAF1 +/+ dermal ®broblasts isolated from newborn Balb/c mice and cultured for 24 h; combined cell pellets were grafted in a 1 cm diameter chamber onto the dorsal surface of nude mice as previously described (Weinberg et al., 1994) . Tumors from keratinocytes of p21 CIP1/WAF1 +/+, +/7 and 7/7 genotypes were derived from six, 11 and ®ve independent cell preparations which were not pooled, so that each one or two grafts represents cells derived from a single mouse, an important protocol step to eliminate individual dierences. At 15 and 21 days following grafting, tumors were measured at the largest portion of each dimension and total tumor volume was calculated as the product of length6width6height. Mice were injected with bromodeoxyuridine (BrdU) (Sigma Chemical Co., 250 mg/g body weight in saline solution) by intraperitoneal injection 1 h prior to sacri®ce by cervical dislocation 22 days after grafting. (Transduction Laboratories, Lexington, KY) or anity puri®ed rabbit anti-keratin 14 (Tennenbaum et al., 1993) and HRP-conjugated donkey anti-mouse or rabbit IgG (Jackson Immunoresearch Laboratories, Inc., West Grove, PA); binding was visualized using chemiluminescence detection system (Pierce, Rockford, IL).
Immunohistochemistry
Tumor sections were stained for expression of keratins 1, 13 and 8 as previously described (Tennenbaum et al., 1993) . BrdU incorporation was recognized by sequential incubation with mouse anti-BrdU antibody (Becton Dickinson, San Jose, CA) and biotinylated goat anti-mouse IgG (Jackson Laboratories) and visualized with Histomark Black (Kirkegaard & Perry Labs, Gaithersburg, MD). Labelling index was determined by counting total BrdU labelled nuclei/100 nuclei within a papilloma. 2000 nuclei total were counted from two tumors of each genotype.
In vitro response to growth inhibitors
The contribution of p21 CIP1/WAF1 to negative growth regulation by TGF-b and Ca 2+ was assayed by thymidine incorporation as previously described (Weinberg et al., 1994) . Keratinocytes were isolated from the skins of each 
